-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

311.O3.6 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Clinical Practice, Natural History, and Patient Reported Outcomes

Symposia: Disorders of Platelet Number or Function: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Bleeding and Clotting, drug development, Diseases, thrombocytopenias, Immune Disorders, Therapies, Adverse Events
Sunday, December 10, 2023: 9:30 AM-11:00 AM
Room 30 (San Diego Convention Center)
Taylor Olmsted Kim, MD, ARRAY(0xeb104c8) and Kirsty Hillier, MD, ARRAY(0xf264248)
No relevant conflicts of interest to declare.
10:45 AM

Ahmad M Tarawah, MD1*, Tarek M Owaidah, MD, FRCPA2,3,4, Raghad A Tarawah, MD5*, Saud Balelah, MD6*, Mohammed A Zolaly7*, Asim Abdullah Alamri, MD8*, Waheed A Turkistani, MD9*, Insherah Barnawi, MD10*, Mohamed Hisham Fakher, MD11* and Zakaria Al hawsawi, MD12*

1Madinah Hereditary Blood Disorders Centre, King Salman bin Abdulaziz Medical city, Madinah, Saudi Arabia
2National Blood and Cancer Center, Riyadh, Saudi Arabia
3alfaisal university, Riyadh, Saudi Arabia
4King Faisal Specialist Hosp. and Rsch. Ctr., AR Riyadh, AR Riyadh, Saudi Arabia
5Department of Medicine, King Fahad hospital, Madinah, Saudi Arabia
6King Salman bin Abdulaziz Medical City, Madinah, Saudi Arabia
7College of Medicine, Taibah University, Madinah, Saudi Arabia
8King Salman bin Abdulaziz Medical city, Madinah, Saudi Arabia
9King Salman bin Abdulaziz Medical City, Madinah, Saudi Arabia
10King Fahad hospital, Medina, Saudi Arabia
11Regional blood bank, Madinah, Saudi Arabia
12Health care medical complex, Madinah, Saudi Arabia

9:30 AM

David J Kuter, MD, DPhil1, Imene Gouia, PharmD, MSc Health Economics2*, Matias Cordoba, MD3*, Brad Ward, PharmD4*, Ines Hemim, PharmD, MSc Health Economics5*, Duane Madziva, MPH5* and Natalia Petruski-Ivleva, PhD, MS5*

1Hematology Division, Massachusetts General Hospital, Boston, MA
2Sanofi, Gentilly, France
3Sanofi, Cambridge, MA
4US Medical, Sanofi, Cambridge, MA
5HEVA, Sanofi, Cambridge, MA

9:45 AM

Zain Virk, MD1*, Rebecca Karp Leaf, MD2, David J Kuter, MD, DPhil3,4, Katayoon Goodarzi, MD2*, Nathan T. Connell, MD, MPH4,5, Jean M. Connors, MD6 and Hanny Al-Samkari, MD4,7

1Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
2Massachusetts General Hospital, Boston, MA
3Hematology Division, Massachusetts General Hospital, Boston, MA
4Harvard Medical School, Boston, MA
5Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA
6Dana-Farber Cancer Institute, Boston, MA
7Division of Hematology Oncology, Massachusetts General Hospital, Boston, MA

10:00 AM

Elizabeth King, PharmD1*, Uzo Abajue, PharmD2*, Amanda Pawlenty, PharmD2*, Huong Lan Truong, PharmD2*, Sabrina Fischer, PharmD3*, Alexandra P. Wolanskyj-Spinner, MD4, Rajiv K. Pruthi, M.B.B.S.5, Carl C. Hook, MD6, Animesh D. Pardanani, MBBS, PhD7, Aneel Ashrani, MBBS, MSc8, Ewa Wysokinska, MD9, Surbhi Shah, MD10 and Ronald S. Go, MD11

1Department of Pharmacy, Mayo Clinic - Rochester, Oronoco, MN
2Department of Pharmacy, Mayo Clinic - Rochester, Rochester, MN
3Department of Pharmacy, Mayo Clinic - Jacksonville, Jacksonville, FL
4Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
5Comprehensive Hemophilia Center and Special Coagulation Laboratory, Division of Hematopathology, Mayo Clinic, Rochester, MN
6Mayo Clinic, Rochester, MN
7Division of Hematology, Mayo Clinic, Rochester, MN
8Mayo Clinic College of Medicine, Rochester, MN
9Mayo Clinic, Jacksonville, FL
10Arizona, Mayo Clinic, Scottsdale, AZ
11Mayo Clinic, Onalaska, WI

10:15 AM

Anna Frandsen1,2*, Nikolaj Mannering2,3*, Dennis Lund Hansen2,3*, Tarec Christoffer Christoffer El-Galaly, MD, DSc2,3,4,5, Lasse Hjort Jakobsen, MSc, PhD6* and Henrik Frederiksen, MD, PhD2,3

1Department of Clinical Research, University of Southern Denmark, Odense C, Denmark
2Department of Hematology, Odense University Hospital, Odense, Denmark
3Department of Clinical Research, University of Southern Denmark, Odense, Denmark
4Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
5Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden
6Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark

10:30 AM

Anne Rudbeck Juhl, MD1,2,3*, Andreas Glenthoej, MD, PhD1,2, Boerge Groenne Nordestgaard, MD, DMSci2,3,4*, Jesper Petersen, PhD1*, Morten Dahl, MD, PhD, DMSci2,5*, Christina Ellervik, MD, PhD, DMSci, MMSci2,6,7,8*, Stig Egil Bojesen, MD, DMSci2,3,4* and Jens Helby, MD, PhD1,3*

1Danish Red Blood Cell Center, Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
2Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
3The Copenhagen General Population Study, Copenhagen University Hospital – Herlev and Gentofte, Herlev, Denmark
4Department of Clinical Biochemistry, Copenhagen University Hospital – Herlev and Gentofte, Herlev, Denmark
5Department of Clinical Biochemistry, Zealand University Hospital, Koege, Denmark
6Department of Pathology, Harvard Medical School, Boston, MA
7Department of Production, Research, and Innovation, Region Zealand, Soroe, Denmark
8Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA

*signifies non-member of ASH